|
Path A Air pollutant -> immune marker
|
Path B Immune marker + air pollutant -> outcome
|
|---|
| |
Beta
|
95% CI
|
p
| | |
OR
|
95% CI
|
p
|
|---|
|
NO2 -> IL-6
|
− 0.05
|
(− 0.08, − 0.03)
|
< 0.001
|
NO2 + IL-6 -> ASD w/ ID
|
0.99
|
(0.97, 1.02)
|
0.57
|
|
1.11
|
(1.03, 1.20)
|
0.01a
|
|
NO2 -> IL-8
|
− 0.03
|
(− 0.05, − 0.02)
|
< 0.001
|
NO2 + IL-8-> ASD w/ ID
|
0.99
|
(0.97, 1.01)
|
0.44
|
|
1.09
|
(0.96, 1.24)
|
0.18
|
|
NO2 -> MCP-1
|
− 0.02
|
(− 0.03, − 0.01)
|
< 0.001
|
NO2 + MCP-1-> ASD w/ ID
|
0.99
|
(0.97, 1.01)
|
0.40
|
|
1.10
|
(0.89, 1.36)
|
0.37
|
|
Ozone -> IL-8
|
0.02
|
(0.01, 0.03)
|
< 0.001
|
Ozone + IL-8-> ASD w/ ID
|
1.00
|
(0.99, 1.02)
|
0.64
|
|
1.09
|
(0.96, 1.24)
|
0.16
|
|
NO2 -> MCP-1
|
− 0.02
|
(− 0.02, − 0.01)
|
< 0.001
|
NO2 + MCP-1-> ASD w/o ID
|
0.99
|
(0.97, 1.02)
|
0.58
|
|
0.77
|
(0.62, 0.97)
|
0.03a
|
|
Ozone -> IL-8
|
0.02
|
(0.01, 0.03)
|
< 0.001
|
Ozone + IL-8-> ASD w/o ID
|
1.00
|
(0.99, 1.02)
|
0.67
|
|
0.88
|
(0.78, 0.99)
|
0.03a
|
|
NO2 -> IL-10
|
− 0.03
|
(− 0.05, − 0.02)
|
< 0.001
|
NO2 + IL-10-> ASD w/o ID
|
0.99
|
(0.96, 1.01)
|
0.32
|
|
0.98
|
(0.87, 1.10)
|
0.74
|
|
NO2 -> IL-6
|
− 0.05
|
(− 0.07, − 0.02)
|
< 0.001
|
NO2 + IL-6-> ID w/o ASD
|
0.99
|
(0.96, 1.01)
|
0.29
|
|
0.97
|
(0.89, 1.05)
|
0.45
|
|
NO2 -> IL-8
|
− 0.03
|
(− 0.04, − 0.01)
|
< 0.001
|
NO2 + IL-8-> ID w/o ASD
|
0.99
|
(0.96, 1.01)
|
0.29
|
|
0.94
|
(0.82, 1.08)
|
0.40
|
|
NO2 -> MCP-1
|
− 0.02
|
(− 0.03, − 0.01)
|
< 0.001
|
NO2 + MCP-1-> ID w/o ASD
|
0.99
|
(0.96, 1.01)
|
0.31
|
|
0.94
|
(0.74, 1.2)
|
0.63
|
- Ten candidate mediation models were carried out based on significant associations between air pollutants and immune markers (p < 0.001) in supplemental tables 3–5
- aThis model is shown in Fig. 2. Air pollutants measured in parts per billion (NO2, ozone) or microgram/meters3 (PM2.5, PM10)